Daliresp is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Cardinal Health. The primary component is Roflumilast.
Product ID | 55154-4625_c4271d86-cc5f-4ed0-bf0d-fefcd6aa1e77 |
NDC | 55154-4625 |
Product Type | Human Prescription Drug |
Proprietary Name | Daliresp |
Generic Name | Roflumilast |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2011-02-28 |
Marketing Category | NDA / NDA |
Application Number | NDA022522 |
Labeler Name | Cardinal Health |
Substance Name | ROFLUMILAST |
Active Ingredient Strength | 500 ug/1 |
Pharm Classes | Phosphodiesterase 4 Inhibitor [EPC],Phosphodiesterase 4 Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2011-02-28 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA022522 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2011-02-28 |
Marketing End Date | 2016-07-31 |
Ingredient | Strength |
---|---|
ROFLUMILAST | 500 ug/1 |
SPL SET ID: | 7ac9cc61-b860-478a-92bf-8a54c89f5b32 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0310-0088 | Daliresp | roflumilast |
0310-0095 | Daliresp | roflumilast |
55154-4625 | Daliresp | roflumilast |
0378-1905 | Roflumilast | Roflumilast |
13668-476 | Roflumilast | Roflumilast |
31722-623 | Roflumilast | Roflumilast |
42571-259 | ROFLUMILAST | Roflumilast |
43547-005 | ROFLUMILAST | roflumilast |
64380-786 | roflumilast | ROFLUMILAST |
68382-969 | Roflumilast | Roflumilast |
70771-1674 | Roflumilast | Roflumilast |
72205-200 | Roflumilast | Roflumilast |
72205-201 | Roflumilast | Roflumilast |
80610-130 | roflumilast | roflumilast |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
DALIRESP 85265098 4055617 Live/Registered |
Nycomed GmbH 2011-03-11 |
DALIRESP 77947508 4003351 Live/Registered |
Nycomed GmbH 2010-03-01 |
DALIRESP 75876181 not registered Dead/Abandoned |
ALTANA PHARMA AG 1999-12-21 |